An attempt to patent a medicine already patented in the U.S. and elsewhere, and currently being developed by U.S. drugmaker Gilead Sciences, raises serious intellectual
Tag: pharmaceutical companies
New venture boosts leading medical researchers & their IP rights
A unique public-private partnership provides medical research centers and the patents they generate with a more efficient and rewarding path toward commercialization. Bridge Medicines is a drug discovery
Technology companies back as top patent defendants in 2016
While it may seem like all of the patent infringement targets are large technology companies in 2015, at least 7 of the top 10 defendants
Pharma Cos Face "Patent Cliff" as Protection Expires
Ten Blockbusters will End in Two Years – An article in Daily Finance says that patents that are expiring on many top-selling drugs will cause pharmaceutical
ipcloseup.com 